|
gptkbp:instanceOf
|
gptkb:biotechnology
|
|
gptkbp:CEO
|
gptkb:Ryan_Watts
|
|
gptkbp:collaboratesWith
|
gptkb:Takeda
gptkb:Biogen
gptkb:Sanofi
|
|
gptkbp:focusesOn
|
gptkb:Alzheimer's_disease
gptkb:Parkinson's_disease
gptkb:ALS
neurodegenerative diseases
frontotemporal dementia
|
|
gptkbp:foundedYear
|
2013
|
|
gptkbp:founder
|
gptkb:Ryan_Watts
gptkb:Alexander_Schuth
gptkb:Carole_Ho
gptkb:Marc_Tessier-Lavigne
|
|
gptkbp:headquartersLocation
|
gptkb:South_San_Francisco,_California,_United_States
|
|
gptkbp:industry
|
gptkb:biotechnology
|
|
gptkbp:mission
|
Defeat neurodegenerative diseases
|
|
gptkbp:notableProduct
|
gptkb:DNL151
gptkb:DNL310
gptkb:DNL758
|
|
gptkbp:numberOfEmployees
|
201-500
|
|
gptkbp:stockSymbol
|
gptkb:DNLI
|
|
gptkbp:tradedOn
|
gptkb:NASDAQ
|
|
gptkbp:website
|
https://www.denalitherapeutics.com/
|
|
gptkbp:bfsParent
|
gptkb:Arch_Venture_Partners
gptkb:Jay_Flatley
gptkb:Alexandria_Venture_Investments
gptkb:F-Prime_Capital
gptkb:F-Prime_Capital_Partners
gptkb:Samsara_BioCapital
|
|
gptkbp:bfsLayer
|
6
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
Denali Therapeutics
|